Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity

Frontiers in Immunology

Volumn 5, Issue NOV, 2014, Pages

  Kimani, Stanley Gititu ^a   Geng, Ke ^a   Kasikara, Canan ^a   Kumar, Sushil ^a   Sriram, Ganapathy ^a   Wu, Yi ^b,c   Birge, Raymond B ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptotic cells; Apoptotic versus non apoptotic PS externalization; Autoimmunity; Phosphatidylserine; Scramblases

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMINOPHOSPHOLIPID; BAVITUXIMAB; CASPASE 3; CD14 ANTIGEN; CD36 ANTIGEN; CD68 ANTIGEN; CELL MEMBRANE PROTEIN; CXCL16 CHEMOKINE; FAS LIGAND; INTERLEUKIN 10; KIDNEY INJURY MOLECULE 1; LACTADHERIN; LIPOCORTIN 2; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; SCAVENGER RECEPTOR F; SCAVENGER RECEPTOR F1; SCRAMBLASE; T CELL MEMBRANE PROTEIN 4; TRANSFORMING GROWTH FACTOR BETA; TRANSMEMBRANE PROTEIN 16F; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; UNINDEXED DRUG; XKR8 PROTEIN;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CAENORHABDITIS ELEGANS; CANCER IMMUNOTHERAPY; CHRONIC INFLAMMATION; CYTOLOGY; DISEASE COURSE; DNA SEQUENCE; EFFEROCYTOSIS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GLOMERULONEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEMBRANE MARKER; NEUTROPHIL; NONHUMAN; PHAGOCYTE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TUMOR MICROENVIRONMENT;

EID: 84919400992     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00566     Document Type: Article

References (104)

1. Maderna P, Godson C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta (2003) 1639:141-51. doi: 10.1016/j.bbadis.2003.09.004
2. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol (2002) 2:965-75. doi:10.1038/nri957
3. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature (2000) 407:784-8. doi:10.1038/35037722
4. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature (1997) 390:350-1. doi:10.1038/37022
5. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 6:280-9. doi:10.1038/nrrheum.2010.46
6. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum (2002) 46:191-201. doi:10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K
7. Shao WH, Cohen PL. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther (2011) 13:202. doi:10.1186/ar3206
8. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol (1992) 148:2207-16.
9. Martin SJ, Reutelingsperger CPM, Mcgahon AJ, Rader JA, Vanschie RCAA, Laface DM, et al. Early redistribution of plasma-membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus - inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 182:1545-56. doi:10.1084/jem.182.5.1545
10. Wu Y, Tibrewal N, Birge RB. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol (2006) 16:189-97. doi:10.1016/j.tcb.2006.02.003
11. Zirngibl M, Furnrohr BG, Janko C, Munoz LE, Voll RE, Gregory CD, et al. Loading of nuclear autoantigens prototypically recognized by SLE sera into late apoptotic vesicles requires intact microtubules and MLCK activity. Clin Exp Immunol (2014). doi:10.1111/cei.12342
12. Liang YY, Arnold T, Michlmayr A, Rainprecht D, Perticevic B, Spittler A, et al. Serum-dependent processing of late apoptotic cells for enhanced efferocytosis. Cell Death Dis (2014) 5:e1264. doi:10.1038/cddis.2014.210
13. Schmid M, Hunold K, Weber-Steffens D, Mannel DN. Ficolin-B marks apoptotic and necrotic cells. Immunobiology (2012) 217:610-5. doi:10.1016/j.imbio.2011.10.020
14. Bijl M, Horst G, Bijzet J, Bootsma H, Limburg PC, Kallenberg CG. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. Arthritis Rheum (2003) 48:248-54. doi:10.1002/art.10737
15. Janko C, Franz S, Munoz LE, Siebig S, Winkler S, Schett G, et al. CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front Immunol (2011) 2:70. doi:10.3389/fimmu.2011.00070
16. van Rossum AP, Fazzini F, Limburg PC, Manfredi AA, Rovere-Querini P, Mantovani A, et al. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum (2004) 50:2667-74. doi:10.1002/art.20370
17. Franz S, Herrmann K, Furnrohr BG, Sheriff A, Frey B, Gaipl US, et al. After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ (2007) 14:733-42. doi:10.1038/sj.cdd.4402066
18. Hart SP, Smith JR, Dransfield I. Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement. Clin Exp Immunol (2004) 135:181-5. doi:10.1111/j.1365-2249.2003.02330.x
19. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (2000) 405:85-90. doi:10.1038/35011084
20. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest (2002) 109:41-50. doi:10.1172/JCI200211638
21. Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med (2001) 7:215-21. doi:10.1038/84667
22. Wu CS, Hu CY, Chan CJ, Chang SK, Hsu PN. Genetic polymorphism of the growth arrest-specific 6 gene is associated with cutaneous vasculitis in Taiwanese patients with systemic lupus erythematosus. Clin Rheumatol (2012) 31:1443-8. doi:10.1007/s10067-012-2027-z
23. Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest (2009) 119:2942-53. doi:10.1172/JCI39325
24. Bertolaccini ML, Sanna G, Ralhan S, Gennari LC, Merrill JT, Khamashta MA, et al. Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost (2003) 90:636-41. doi:10.1160/TH03-03-0151
25. Song KS, Park YS, Kim HK. Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum (2000) 43:557-60. doi:10.1002/1529-0131(200003)43:3<557::AID-ANR11>3.0.CO;2-O
26. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science (2004) 304:1147-50. doi:10.1126/science.1094359
27. Hu CY, Wu CS, Tsai HF, Chang SK, Tsai WI, Hsu PN. Genetic polymorphism in milk fat globule-EGF factor 8 (MFG-E8) is associated with systemic lupus erythematosus in human. Lupus (2009) 18:676-81. doi:10.1177/0961203309103027
28. Yamaguchi H, Fujimoto T, Nakamura S, Ohmura K, Mimori T, Matsuda F, et al. Aberrant splicing of the milk fat globule-EGF factor 8 (MFG-E8) gene in human systemic lupus erythematosus. Eur J Immunol (2010) 40:1778-85. doi:10.1002/eji.200940096
29. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 19:56-9. doi:10.1038/ng0598-56
30. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology (1998) 199:265-85. doi:10.1016/S0171-2985(98)80032-6
31. Stuart LM, Takahashi K, Shi L, Savill J, Ezekowitz RAB. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol (2005) 174:3220-6. doi:10.4049/jimmunol.174.6.3220
32. Davies EJ, Snowden N, Hillarby MC, Carthy D, Grennan DM, Thomson W, et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum (1995) 38:110-4. doi:10.1002/art.1780380117
33. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum (1998) 41:1663-8.
34. Mesaeli N, Nakamura K, Zvaritch E, Dickie P, Dziak E, Krause KH, et al. Calreticulin is essential for cardiac development. J Cell Biol (1999) 144:857-68. doi:10.1083/jcb.144.5.857
35. Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science (2001) 293:306-11. doi:10.1126/science.1061663
36. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med (2002) 196:135-40. doi:10.1084/jem.20012094
37. Ma GZ, Stankovich J, Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Kilpatrick TJ, Binder MD, Field J. Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility. PLoS One (2011) 6:e16964. doi:10.1371/journal.pone.0016964
38. Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol (2009) 86:1089-95. doi:10.1189/jlb.0209115
39. Zizzo G, Guerrieri J, Dittman LM, Merri JT, Cohen PL. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity. Arthritis Res Ther (2013) 15:R212. doi:10.1186/ar4407
40. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature (2007) 450:435-9. doi:10.1038/nature06307
41. Tian L, Choi SC, Murakami Y, Allen J, Morse HC III, Qi CF, et al. p85alpha recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression. Nat Commun (2014) 5:3146. doi:10.1038/ncomms4146
42. Ramirez-Ortiz ZG, Pendergraft WF III, Prasad A, Byrne MH, Iram T, Blanchette CJ, et al. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat Immunol (2013) 14:917-26. doi:10.1038/ni.2670
43. Schledzewski K, Geraud C, Arnold B, Wang S, Grone HJ, Kempf T, et al. Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J Clin Invest (2011) 121:703-14. doi:10.1172/JCI44740
44. He M, Kubo H, Morimoto K, Fujino N, Suzuki T, Takahasi T, et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep (2011) 12:358-64. doi:10.1038/embor.2011.28
45. Martens HA, Nienhuis HL, Gross S, van der Steege G, Brouwer E, Berden JH, et al. Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis. Lupus (2012) 21:959-68. doi:10.1177/0961203312444495
46. Herz J, Clouthier DE, Hammer RE. Ldl receptor-related protein internalizes and degrades Upa-Pai-1 complexes and is essential for embryo implantation. Cell (1992) 71:411-21. doi:10.1016/0092-8674(92)90511-A
47. Gorovoy M, Gaultier A, Campana WM, Firestein GS, Gonias SL. Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages. J Leukoc Biol (2010) 88:769-78. doi:10.1189/jlb.0410220
48. Bratton DL, Henson PM. Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up? Curr Biol (2008) 18:R76-9. doi:10.1016/j.cub.2007.11.024
49. Hochreiter-Hufford A, Ravichandran KS. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol (2013) 5:a008748. doi:10.1101/cshperspect.a008748
50. Poon IKH, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol (2014) 14:166-80. doi:10.1038/nri3607
51. Xiao S, Brooks CR, Zhu C, Wu C, Sweere JM, Petecka S, et al. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci U S A (2012) 109:12105-10. doi:10.1073/pnas.1120914109
52. Miyanishi M, Segawa K, Nagata S. Synergistic effect of Tim4 and MFG-E8 null mutations on the development of autoimmunity. Int Immunol (2012) 24:551-9. doi:10.1093/intimm/dxs064
53. Kinchen JM, Ravichandran KS. Phagocytic signaling: you can touch, but you can't eat. Curr Biol (2008) 18:R521-4. doi:10.1016/j.cub.2008.04.058
54. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell (2004) 14:277-87. doi:10.1016/S1097-2765(04)00237-0
55. Finnemann SC, Nandrot EF. MerTK activation during RPE phagocytosis in vivo requires alphaVbeta5 integrin. Adv Exp Med Biol (2006) 572:499-503. doi:10.1007/0-387-32442-9_69
56. Wu Y, Singh S, Georgescu MM, Birge RB. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci (2005) 118:539-53. doi:10.1242/jcs.01632
57. Wu J, Ekman C, Jonsen A, Sturfelt G, Bengtsson AA, Gottsater A, et al. Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis. Arthritis Res Ther (2011) 13:R62. doi:10.1186/ar3316
58. Zhu H, Sun X, Zhu L, Hu F, Shi L, Li Z, et al. The expression and clinical significance of different forms of mer receptor tyrosine kinase in systemic lupus erythematosus. J Immunol Res (2014). doi:10.1155/2014/431896
59. Hilliard BA, Zizzo G, Ulas M, Linan MK, Schreiter J, Cohen PL. Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy. Arthritis Res Ther (2014) 16:R76. doi:10.1186/ar4517
60. Majai G, Kiss E, Tarr T, Zahuczky G, Hartman Z, Szegedi G, et al. Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients. Lupus (2014) 23:133-45. doi:10.1177/0961203313511557
61. Suh CH, Hilliard B, Li S, Merrill JT, Cohen PL. TAM receptor ligands in lupus: protein S but not gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther (2010) 12:R146. doi:10.1186/ar3088
62. Paidassi H, Tacnet-Delorme P, Verneret M, Gaboriaud C, Houen G, Duus K, et al. Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition. J Mol Biol (2011) 408:277-90. doi:10.1016/j.jmb.2011.02.029
63. Martin M, Leffler J, Blom AM. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem (2012) 287:33733-44. doi:10.1074/jbc.M112.341339
64. Mikolajczyk T, Skiba D, Batko B, Krezelok M, Wilk G, Osmenda G, et al. Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus. Lupus (2014):1-12. doi:10.1177/0961203314541316
65. Tas SW, Quartier P, Botto M, Fossati-Jimack L. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis (2006) 65:216-21. doi:10.1136/ard.2005.037143
66. Donnelly S, Roake W, Brown S, Young P, Naik H, Wordsworth P, et al. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum (2006) 54:1543-56. doi:10.1002/art.21783
67. Lauber K, Keppeler H, Munoz LE, Koppe U, Schroder K, Yamaguchi H, et al. Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids. Cell Death Differ (2013) 20:1230-40. doi:10.1038/cdd.2013.82
68. Zagorska A, Traves PG, Lew ED, Dransfield I, Lemke G. Diversification of TAM receptor tyrosine kinase function. Nat Immunol (2014) 15:920-8. doi:10.1038/ni.2986
69. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity (2009) 31:245-58. doi:10.1016/j.immuni.2009.06.018
70. Zahuczky G, Kristof E, Majai G, Fesus L. Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages. Role of Mertk in enhanced phagocytosis. PLoS One (2011) 6:e21349. doi:10.1371/journal.pone.0021349
71. Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys (2010) 39:407-27. doi:10.1146/annurev.biophys.093008.131234
72. Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res (2003) 44:233-42. doi:10.1194/jlr.R200019-JLR200
73. Marino G, Kroemer G. Mechanisms of apoptotic phosphatidylserine exposure. Cell Res (2013) 23:1247-8. doi:10.1038/cr.2013.115
74. Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature (2010) 468:834-8. doi:10.1038/nature09583
75. Yang H, Kim A, David T, Palmer D, Jin T, Tien J, et al. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell (2012) 151:111-22. doi:10.1016/j.cell.2012.07.036
76. Suzuki J, Denning DP, Imanishi E, Horvitz HR, Nagata S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science (2013) 341:403-6. doi:10.1126/science.1236758
77. Suzuki J, Fujii T, Imao T, Ishihara K, Kuba H, Nagata S. Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J Biol Chem (2013) 288:13305-16. doi:10.1074/jbc.M113.457937
78. Segawa K, Suzuki J, Nagata S. Constitutive exposure of phosphatidylserine on viable cells. Proc Natl Acad Sci U S A (2011) 108:19246-51. doi:10.1073/pnas.1114799108
79. Stanfield GM, Horvitz HR. The ced-8 gene controls the timing of programmed cell deaths in C. elegans. Mol Cell (2000) 5:423-33. doi:10.1016/S1097-2765(00)80437-2
80. Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Matsuda F, Nagata S. Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science (2014) 344:1164-8. doi:10.1126/science.1252809
81. Clark SR, Thomas CP, Hammond VJ, Aldrovandi M, Wilkinson GW, Hart KW, et al. Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation. Proc Natl Acad Sci U S A (2013) 110:5875-80. doi:10.1073/pnas.1222419110
82. Tyurin VA, Yanamala N, Tyurina YY, Klein-Seetharaman J, Macphee CH, Kagan VE. Specificity of lipoprotein-associated phospholipase A(2) toward oxidized phosphatidylserines: liquid chromatography-electrospray ionization mass spectrometry characterization of products and computer modeling of interactions. Biochemistry (2012) 51:9736-50. doi:10.1021/bi301024e
83. Tsou WI, Nguyen KQ, Calarese DA, Garforth SJ, Antes AL, Smirnov SV, et al. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation. J Biol Chem (2014) 289:25750-63. doi:10.1074/jbc.M114.569020
84. Fadok VA, Bratton DL, Henson PM. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest (2001) 108:957-62. doi:10.1172/JCI200114122
85. Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, et al. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic Biol Med (2004) 37:1963-85. doi:10.1016/j.freeradbiomed.2004.08.016
86. Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenström-Magnusson C, Liu S-X, et al. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J Immunol (2002) 169:487-99. doi:10.4049/jimmunol.169.1.487
87. Chang MK, Bergmark C, Laurila A, Horkko S, Han KH, Friedman P, et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A (1999) 96:6353-8. doi:10.1073/pnas.96.11.6353
88. Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med (2006) 203:2613-25. doi:10.1084/jem.20060370
89. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ (2008) 15:243-50. doi:10.1038/sj.cdd.4402184
90. Tyurin VA, Balasubramanian K, Winnica D, Tyurina YY, Vikulina AS, He RR, et al. Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic 'eat-me' signals: cleavage and inhibition of phagocytosis by Lp-PLA2. Cell Death Differ (2014) 21:825-35. doi:10.1038/cdd.2014.1
91. Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, et al. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med (2009) 15:1266-72. doi:10.1038/nm.2048
92. Roszer T, Menendez-Gutierrez MP, Lefterova MI, Alameda D, Nunez V, Lazar MA, et al. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol (2011) 186:621-31. doi:10.4049/jimmunol.1002230
93. Frasch SC, Bratton DL. Emerging roles for lysophosphatidylserine in resolution of inflammation. Prog Lipid Res (2012) 51:199-207. doi:10.1016/j.plipres.2012.03.001
94. Frasch SC, Fernandez-Boyanapalli RF, Berry KAZ, Murphy RC, Leslie CC, Nick JA, et al. Neutrophils regulate tissue neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine. J Biol Chem (2013) 288:4583-93. doi:10.1074/jbc.M112.438507
95. Kitamura H, Makide K, Shuto A, Ikubo M, Inoue A, Suzuki K, et al. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position. J Biochem (2012) 151:511-8. doi:10.1093/jb/mvs011
96. Makide K, Aoki J. GPR34 as a lysophosphatidylserine receptor. J Biochem (2013) 153:327-9. doi:10.1093/jb/mvt010
97. Frasch SC, Berry KZ, Fernandez-Boyanapalli R, Jin H-S, Leslie C, Henson PM, et al. NADPH Oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A. J Biol Chem (2008) 283:33736-49. doi:10.1074/jbc.M807047200
98. Yin Y, Huang X, Lynn KD, Thorpe PE. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol Res (2013) 1:256-68. doi:10.1158/2326-6066.CIR-13-0073
99. Gerber DE, Stopeck AT, Wong L, Rosen LS, Thorpe PE, Shan JS, et al. Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res (2011) 17:6888-96. doi:10.1158/1078-0432.CCR-11-1074
100. Bondanza A, Zimmermann VS, Rovere-Querini P, Turnay J, Dumitriu IE, Stach CM, et al. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med (2004) 200:1157-65. doi:10.1084/jem.20040327
101. Callahan MK, Popernack PM, Tsutsui S, Truong L, Schlegel RA, Henderson AJ. Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J Immunol (2003) 170:4840-5. doi:10.4049/jimmunol.170.9.4840
102. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe (2012) 12:544-57. doi:10.1016/j.chom.2012.08.009
103. Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol (2013) 87:8327-41. doi:10.1128/JVI.01025-13
104. Morizono K, Chen IS. Role of phosphatidylserine receptors in enveloped virus infection. J Virol (2014) 88:4275-90. doi:10.1128/JVI.03287-13